MRNA - Moderna, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-2.09
|
Rev Est: $239.7M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$34.89
DETAILS
HIGH:
$63.00
LOW:
$17.00
MEDIAN:
$30.00
CONSENSUS:
$34.89
DOWNSIDE:
30.94%
Market Cap:
19.74B
Volume:
6,978,789
Avg Volume:
11,685,975
52 Week Range:
22.28-55.2
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.34
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
5,800
IPO Date:
2018-12-07
EPS (TTM):
-7.26
P/E Ratio:
-4.07
Revenue (TTM):
1.94B
Total Assets:
12.34B
Total Debt:
1.92B
Cash & Equiv:
2.60B
Rev Growth (5Y):
19.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-29.7%
Debt/Equity:
0.22
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-13 | $-2.11 | $-2.60 | +18.8% | $678.0M | $281.3M | +141.0% |
| 2025-11-06 | $-0.51 | $-1.87 | +72.7% | $1.0B | $920.9M | +10.3% |
| 2025-08-01 | $-2.13 | $-2.99 | +28.8% | $142.0M | $893.3M | -84.1% |
| 2025-05-01 | $-2.52 | $-2.92 | +13.7% | $107.0M | $116.7M | -8.3% |
| 2025-02-14 | $-2.50 | $-2.68 | +6.7% | $956.0M | $942.8M | +1.4% |
| 2024-11-07 | $0.03 | $-1.91 | +101.6% | $1.9B | $1.3B | +48.4% |
| 2024-08-01 | $-3.33 | $-3.35 | +0.6% | $241.0M | $128.4M | +87.7% |
| 2024-05-02 | $-3.07 | $-3.56 | +13.8% | $167.0M | $93.3M | +79.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.94B | 3.20B | 6.85B | 18.88B | 17.74B | 803.39M | 60.21M | 135.07M | 205.82M | 108.40M |
| Net Income | (2.82B) | (3.56B) | (4.71B) | 8.36B | 12.20B | (747.06M) | (514.02M) | (384.73M) | (255.92M) | (216.21M) |
| EPS | -7.26 | -9.27 | -12.34 | 21.26 | 30.31 | -1.96 | -1.55 | -1.17 | -0.72 | -3.79 |
| Total Assets | 12.34B | 14.14B | 18.43B | 25.86B | 24.67B | 7.34B | 1.59B | 1.96B | 1.08B | 1.42B |
| Total Debt | 1.92B | 747.00M | 1.24B | 1.20B | 916.00M | 237.00M | 132.36M | 33.49M | 15.69M | 12.50M |
| Cash & Equivalents | 2.60B | 1.93B | 2.91B | 3.21B | 6.85B | 2.62B | 235.88M | 658.36M | 134.86M | 50.08M |
| Operating Cash Flow | (1.87B) | (3.00B) | (3.12B) | 4.98B | 13.62B | 2.03B | (458.97M) | (330.87M) | (331.48M) | 66.73M |
| Free Cash Flow | (2.06B) | (4.05B) | (3.83B) | 4.58B | 13.34B | 1.96B | (490.52M) | (436.63M) | (389.88M) | 33.59M |
| FCF per Share | -5.31 | -10.56 | -10.01 | 11.63 | 33.09 | 5.14 | -1.48 | -1.33 | -1.04 | 0.52 |
| Book Value | 8.65B | 10.90B | 13.85B | 19.12B | 14.14B | 2.56B | 1.17B | 1.53B | 625.30M | 841.85M |
| Cash & ST Investments | 5.80B | 7.03B | 8.60B | 9.90B | 10.73B | 4.61B | 1.10B | 1.52B | 756.03M | 1.06B |
| ROC Equity | -0.33 | -0.33 | -0.34 | 0.44 | 0.86 | -0.29 | -0.44 | -0.25 | -0.41 | -0.26 |